Submission Details
| 510(k) Number | K210321 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2021 |
| Decision Date | March 29, 2022 |
| Days to Decision | 418 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K210321 is an FDA 510(k) clearance for the Dukal Corporation Level 1 Pediatric Face Mask, a Pediatric/child Facemask (Class II — Special Controls, product code OXZ), submitted by Dukal Corporation (Ronkonkoma, US). The FDA issued a Cleared decision on March 29, 2022, 418 days after receiving the submission on February 4, 2021. This device falls under the General Hospital review panel. Regulated under 21 CFR 878.4040.
| 510(k) Number | K210321 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2021 |
| Decision Date | March 29, 2022 |
| Days to Decision | 418 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | OXZ — Pediatric/child Facemask |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4040 |
| Definition | A Pediatric/child Facemask Is Intended To Be Worn By The Patient/child To Provide Protection For The Respiratory Tract. It Is A Single Use, Disposable Device That Is Provided Non-sterile. The Facemask Is Recommended For Use In A Healthcare Setting With Appropriate Adult Supervision. |